article

• Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis.
• Combinatorial, additive and dose-dependent drug–microbiome associations
• High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection
• Insights from pharmacokinetic models of host-microbiome drug metabolism
• Integration of Metabolomics and Transcriptomics Reveals a Complex Diet of Mycobacterium tuberculosis during Early Macrophage Infection
• L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity.
• Mapping human microbiome drug metabolism by gut bacteria and their genes
• Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota
• Next-Generation "-omics" Approaches Reveal a Massive Alteration of Host RNA Metabolism during Bacteriophage Infection of Pseudomonas aeruginosa.
• Regulation of yeast central metabolism by enzyme phosphorylation.
• SUMOFLUX: A Generalized Method for Targeted 13C Metabolic Flux Ratio Analysis.
• Separating host and microbiome contributions to drug pharmacokinetics and toxicity
• The Stringent Response Determines the Ability of a Commensal Bacterium to Survive Starvation and to Persist in the Gut
• Visualizing translation dynamics at atomic detail inside a bacterial cell